Home/ Supplements/ Nac/ Tri-Methyl Xtreme

Tri-Methyl Xtreme

product on market Capsule EPG Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product contains N-Acetyl Cysteine and celery seed extract, which have moderate evidence for antioxidant and diuretic support. The remaining ingredients are synthetic steroid derivatives with very limited clinical research regarding their efficacy and long-term safety. Overall, evidence coverage for this specific ingredient profile is minimal.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Tri-Methyl Xtreme
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 600.0mg (7 products) 39 studies (A:2, B:13)
Market median: 630.0mg (46 products)
2,17a-Dimethyl-5a-Androsta-1-En-17Beta-Ol-3-One
7.5 mg
13-Ethyl-Methoxy-Gona-2 5(10) Dien 17-One
15 mg
2a,3a-Epithio-17a-Methyl-5a-Androstane-17b-Ol
15 mg

Other Ingredients

Rice Flour Gelatin Magnesium Stearate Stearic Acid Silica
Claims

Label Claims — Verification

Unverified No Claim
Info

Product Information

Formulation Notes

Methylsten 7.5 mg 13-Ethyl 15 mg 2a 3a Epi 15 mg

Additional Information

Maximum strength

Metadata

Product Details

DSLD Entry Date2018-11-21
Product TypeOther Combinations
FormCapsule
BrandEPG
DSLD ID182760
Data Updated2026-04-11
Research

Research Evidence

41
Research Sources
51
Avg Quality
19
Rct
13
Meta Analysis
9
Clinical Trial
B N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
B Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial
Rct Nature communications 2024 PubMed DOI
B N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Meta Analysis European respiratory review : an official journal of the European Respiratory Society 2015 PubMed DOI
B A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Rct BMC medicine 2019 PubMed DOI
B Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024 PubMed DOI
B Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates
Meta Analysis The Cochrane database of systematic reviews 2006 PubMed
B N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Bipolar disorders 2021 PubMed DOI
B N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials
Meta Analysis Psychopharmacology 2020 PubMed DOI
B N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Meta Analysis Archivos de bronconeumologia 2024 PubMed DOI
View all evidence for Nac →
Compare

Similar Products

View all Nac products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.